135 related articles for article (PubMed ID: 2006715)
21. DNA ploidy, S-phase, and steroid receptors in more than 127,000 breast cancer patients.
Wenger CR; Beardslee S; Owens MA; Pounds G; Oldaker T; Vendely P; Pandian MR; Harrington D; Clark GM; McGuire WL
Breast Cancer Res Treat; 1993 Oct; 28(1):9-20. PubMed ID: 8123871
[TBL] [Abstract][Full Text] [Related]
22. Tumour heterogeneity of DNA cell cycle variables in breast cancer measured by flow cytometry.
Bergers E; van Diest PJ; Baak JP
J Clin Pathol; 1996 Nov; 49(11):931-7. PubMed ID: 8944615
[TBL] [Abstract][Full Text] [Related]
23. Is DNA ploidy an independent prognostic indicator in infiltrative node-negative breast adenocarcinoma?
Keyhani-Rofagha S; O'Toole RV; Farrar WB; Sickle-Santanello B; DeCenzo J; Young D
Cancer; 1990 Apr; 65(7):1577-82. PubMed ID: 2311069
[TBL] [Abstract][Full Text] [Related]
24. AgNORs in ductal breast cancer: correlation with ploidy and S-phase fraction by DNA flow cytometry.
Borgiani L; Cogorno P; Oliviero J; Toso F; Gambini G; Tunesi G; Canepa M
Eur J Histochem; 1994; 38(2):171-6. PubMed ID: 7524814
[TBL] [Abstract][Full Text] [Related]
25. DNA ploidy is an independent predictor of survival in breast invasive ductal carcinoma: a long-term multivariate analysis of 393 patients.
Pinto AE; Pereira T; Santos M; Branco M; Dias A; Silva GL; Ferreira MC; André S
Ann Surg Oncol; 2013 May; 20(5):1530-7. PubMed ID: 23250736
[TBL] [Abstract][Full Text] [Related]
26. Static and flow cytometric DNA analysis compared to histologic prognostic factors in a cohort of stage T2 breast cancer.
Arnerlöv C; Emdin SO; Roos G; Angström T; Bjersing L; Angquist KA; Jonsson H
Eur J Surg Oncol; 1990 Jun; 16(3):200-8. PubMed ID: 2347415
[TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of DNA ploidy determined by high-resolution flow cytometry in breast carcinoma.
Bracko M; Us-Krasovec M; Cufer T; Lamovec J; Zidar A; Goehde W
Anal Quant Cytol Histol; 2001 Feb; 23(1):56-66. PubMed ID: 11233744
[TBL] [Abstract][Full Text] [Related]
28. Biologic tumor markers, lymph node status, and decision about adjuvant chemotherapy for breast cancer.
Velanovich V
Am Surg; 1997 Apr; 63(4):330-3. PubMed ID: 9124752
[TBL] [Abstract][Full Text] [Related]
29. Flow cytometric DNA ploidy and S-phase fraction correlate with histopathologic indicators of tumor behavior in colorectal carcinoma.
Pinto AE; Chaves P; Fidalgo P; Oliveira AG; Leitão CN; Soares J
Dis Colon Rectum; 1997 Apr; 40(4):411-9. PubMed ID: 9106689
[TBL] [Abstract][Full Text] [Related]
30. Prognostic potential of DNA flow cytometry measurements in node-negative breast cancer patients: preliminary analysis of an intergroup study (INT 0076).
Dressler LG; Eudey L; Gray R; Tormey DC; McGuire WL; Gilchrist KW; Clark GM; Osborne CK; Mansour EG; Abeloff MD
J Natl Cancer Inst Monogr; 1992; (11):167-72. PubMed ID: 1627424
[TBL] [Abstract][Full Text] [Related]
31. Flow cytometry vs. Ki67 labelling index in breast cancer: a prospective evaluation of 181 cases.
Martínez-Arribas F; Núñez MJ; Piqueras V; Lucas AR; Sánchez J; Tejerina A; Schneider J
Anticancer Res; 2002; 22(1A):295-8. PubMed ID: 12017306
[TBL] [Abstract][Full Text] [Related]
32. Prognostic value of S-phase fraction in lymph-node-negative breast cancer by image and flow cytometric analysis.
Peiró G; Lerma E; Climent MA; Seguí MA; Alonso MC; Prat J
Mod Pathol; 1997 Mar; 10(3):216-22. PubMed ID: 9071729
[TBL] [Abstract][Full Text] [Related]
33. DNA ploidy analyses in 218 consecutive Pakistani breast cancer patients: does it add anything?
Khan E; Mapara Z; Khan S; Arshad N; Siddiqui T; Pervez S
Pathol Oncol Res; 2001; 7(2):125-8. PubMed ID: 11458275
[TBL] [Abstract][Full Text] [Related]
34. Prognostic significance of DNA ploidy in patients with stage II and stage III colon carcinoma: a prospective flow cytometric study.
Lanza G; Gafà R; Santini A; Maestri I; Dubini A; Gilli G; Cavazzini L
Cancer; 1998 Jan; 82(1):49-59. PubMed ID: 9428479
[TBL] [Abstract][Full Text] [Related]
35. Prognostic significance of proliferative activity and ploidy in node-negative breast cancers.
Silvestrini R; Daidone MG; Del Bino G; Mastore M; Luisi A; Di Fronzo G; Boracchi P
Ann Oncol; 1993 Mar; 4(3):213-9. PubMed ID: 8471553
[TBL] [Abstract][Full Text] [Related]
36. A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate.
Ahlgren G; Lindholm K; Falkmer U; Abrahamsson PA
Urology; 1997 Sep; 50(3):379-84. PubMed ID: 9301701
[TBL] [Abstract][Full Text] [Related]
37. DNA flow cytometry and pathologic grading as prognostic guides in axillary lymph node-negative breast cancer.
Merkel DE; Winchester DJ; Goldschmidt RA; August CZ; Wruck DM; Rademaker AW
Cancer; 1993 Sep; 72(6):1926-32. PubMed ID: 8364870
[TBL] [Abstract][Full Text] [Related]
38. Predictive value of flow cytometry for metastatic potential in breast cancer.
Schmidt H; Wei JP; Yeh KA
Am Surg; 1999 May; 65(5):434-8. PubMed ID: 10231212
[TBL] [Abstract][Full Text] [Related]
39. DNA flow cytometry and prognostic factors in 1331 frozen breast cancer specimens.
Dressler LG; Seamer LC; Owens MA; Clark GM; McGuire WL
Cancer; 1988 Feb; 61(3):420-7. PubMed ID: 3338012
[TBL] [Abstract][Full Text] [Related]
40. Prognostic significance of S-phase fraction in good-risk, node-negative breast cancer patients.
Clark GM; Mathieu MC; Owens MA; Dressler LG; Eudey L; Tormey DC; Osborne CK; Gilchrist KW; Mansour EG; Abeloff MD
J Clin Oncol; 1992 Mar; 10(3):428-32. PubMed ID: 1740681
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]